The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)

Published by	Kalorama Information
Published	February, 2010	Product code	112093
Content info	160 pages
Price	US $ 3500 PDF by E-mail (Single User License) US $ 3900 Hard Copy US $ 7000 PDF by E-mail (Global Site License)

Introduction
Related Reports

The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) published by Kalorama Information in February, 2010. This report consists of 160 pages and the price starts from US $ 3500.

Introduction

Abstract

Clinical laboratories are an essential part of the health industry. It is estimated that approximately 80% of physician' s diagnoses are a result of laboratory tests. The constant pressure to reduce healthcare spending is shifting healthcare utilization in favor of the laboratory, making it an ever more valuable part of the treatment plan. As hospital stays are shortened, contact between the physician and patient is reduced, which places a larger role on labs to gather, interpret, and deliver accurate information to the physician in a timely manner. We can expect to see an increase in the number of clinical labs, particularly in the independent sector, as these trends continue to influence the industry.

Since the last time Kalorama Information studied this market two years ago, there have been substantial changes in the industry, including changes in market share as major companies eat into regional labs, new competitors enter the marketplace, and new specialty tests are developed and priced. Clinical Laboratory Services (Markets, Growth Opportunities, Competitive Analysis and Competitor Profiles), provides an in-depth market overview, a total market analysis, analysis by laboratory type, and by routine and specialty testing and a review of the latest trends driving growth. Revenues and forecasts presented are for the U.S. market. Key international markets are discussed as well.

Key market data provided includes:

Hospital, Physician and Independent Lab Statistics
Major Tests Performed by Clinical Lab Companies
Disease Incidence and Trends Driving Lab Business
Market Forecast to 2014
Market Breakdown by Lab Type (Hospital, Physician, Independent)
Market Breakdown by Test Type (Specialty, Routine)
Market Share of Competitors
Competitive Analysis of Leading clinical Lab Providers
The issues and trends which are fueling growth:

A trend towards preventive and risk factor testing has been noted in several disciplines, particularly in the areas of oncology, endocrinology, and gynecology. Physicians in these areas are taking full advantage of testing for early detection and disease prevention. Some of the other issues and trends explored in this study include:

U.S. Demographics
Types of Specialty Tests
Growing Competition
Increasing Life Expectancy
Growing Incidence of Disease
New Product Offerings
Regulatory Environment
Insurance and Reimbursement
Payer Types
Developments in Personalized Medicine

A competitive analysis of leading clinical laboratory providers includes:

Quest Diagnostics, Inc.
Laboratory Corporation of America (LabCorp)
Genomic Health
Genoptix, Inc.
Genzyme Corporation
DaVita
Clarient, Inc.
Spectra Laboratories
Bio-Reference Laboratories

Our methodology:

The information in this report is the result of interviews with executives and market experts, as well as thorough research of secondary sources such as company literature, trade publications and medical and business journals. The emphasis Kalorama puts on primary research guarantees that new insights will be uncovered that are not available from any other source. The most important part of Kalorama' s efforts is its superior analysis of company activities and their true significance in the marketplace.

All market data pertains to the world market at the manufacturers' level. The base year for data was 2009. Historical data was provided for the years 2006, 2007 and 2008, with forecast data provided for 2010 through 2014. Compound annual growth rates (CAGRs) are provided for the 2006-2009 and 2009-2014 periods for each segment covered. A competitive analysis is provided for the year 2009. The forecasted market analysis for 2010-2014 was largely based on demographic trends, new developments, company performance trends, mergers and acquisitions, and national expansion.

CHAPTER ONE: EXECUTIVE SUMMARY

Industry at a Glance
Scope and Methodology
Size and Growth of the Market
Key Issues and Trends Affecting the Market
Leading Market Participants

CHAPTER TWO: INDUSTRY OVERVIEW, REGULATION AND TRENDS

Clinical Laboratory Description
Testing and Services
Routine Testing
- Blood Cell Count
- Cholesterol Level Testing
- HIV Testing
- Anti-HIV-1 Oral Specimen Collection Device
- Anti-HIV-1 Testing Service
- Nucleic Acid Testing
- Human Immunodeficiency Virus Type 1 (Anti-HIV-1 Assay)
- Human Immunodeficiency Virus Types 1 & 2 (Anti-HIV-1/2 Assay)
- Pap Testing
- Pregnancy Testing
- Substance Abuse Testing
- Urinalysis
Specialty Testing
- Endocrinology
- Esoteric Testing
- Genetics
- Immunology and Molecular Microbiology
- Oncology
- Serology
- Toxicology
Industry Structure
- Hospital-based Laboratories
- Physician-office Laboratories
- Independent Clinical Laboratories
Incidence of Diseases
Demographics
- Population Over Age 65
- Life Expectancy
Regulatory Overview
- Certificate of Waiver
- Certificate of Provider-Performed Microscopy Procedures (PPMP)
- Certificate of Compliance and Certificate of Accreditation
- States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
Insurance and Reimbursement
- Laboratory Service Payer Types
- Trends in Medicare Reimbursement
- Commercial Insurance Providers
New Developments in Information Technology
International Markets and Trends

CHAPTER THREE: LEADING MARKET PARTICIPANTS

Summary
Quest Diagnostics, Inc.
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Business Locations
Laboratory Corporation of America
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
Genzyme Corporation
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
DaVita, Inc.
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
Clarient, Inc.
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
Spectra Laboratories
- Company Overview
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
Bio-Reference Laboratories
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
Genomic Health, Inc.
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
Genoptix, Inc.
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations

CHAPTER FIVE: MARKET ANALYSIS

Market Overview
Market Analysis by Laboratory Type
Market Analysis by Test Type
Competitive Analysis

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Figure 1-1: U.S. Clinical Laboratory Market Analysis: 2006-2013

CHAPTER TWO: INDUSTRY OVERVIEW

Table 2-1: Laboratory Reference Parameters for CBC
Table 2-2: High Cholesterol Risk Categories
Table 2-3: HIV Testing Products/Services Approved by the FDA
Table 2-4: HCG Levels in Pregnant Women by Days Past Ovulation
Table 2-5: Substance Detection Periods by Test Method
Table 2-6: Normal Reference Levels in a Medical Urinalysis
Figure 2-1: Growth in Clinical Laboratories, 1997-2008
Table 2-7: U.S. Registered Hospitals by Type, 2006 compared to 2008
Table 2-8: Leading For-Profit U.S. Hospital Chains, 2006, 2007, 2008
Figure 2-2: Trend in For-Profit U.S. Hospital Facilities, 2006-2008
Figure 2-3: Trend in For-Profit U.S. Hospital Licensed Beds, 2006-2008
Figure 2-4: Trend in For-Profit U.S. Hospital Inpatient Admissions, 2006-2008
Table 2-9: Physicians in the US by Specialty, 1970-2008
Table 2-10: Leading U.S. Independent Laboratory Groups, 2008
Table 2-11: U.S. Prevalence of Selected Medical Conditions
Figure 2-5: U.S. Prevalence of Selected Medical Conditions
Table 2-12: The U.S. Population, 1980-2020
Figure 2-6: The US Population, 1980-2020
Table 2-13: Percent U.S. Population Over Age 65 by Year
Figure 2-7: Estimated Population by Age Group, 2000 and 2050
Table 2-14: Average U.S. Life Expectancy in Years 1980, 2004, 2006 and 2008
Figure 2-8: Average U.S. Life Expectancy in Years 1980 and 2008
Table 2-15: Selected CLIA Waived Laboratory Tests
Table 2-16: Provider-Performed Microscopy Procedures
Figure 2-9: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), December 2008
Table 2-17: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), December 2008
Figure 2-10: Clinical Laboratory Certificates Issued by Selected State (non-exempt laboratories only), December 2008
Figure 2-11: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), December 2008
Table 2-18: CLIA Exempt States, Number of Laboratories, 2008
Table 2-19: Health Insurance Trends in the United States, Estimated 2007*
Table 2-20: Clinical Laboratory Clients and Payers by Type
Figure 2-12: Clinical Laboratory Clients and Payers by Type
Table 2-21: Laboratory Fee Schedule for Common CPT Codes in Specialty Testing, 2007-2009
Table 2-21: Leading Commercial Insurance Providers, 2008
Table 2-22: Quest and LabCorp Service Contracts for Leading Insurance Providers

CHAPTER THREE: LEADING MARKET PARTICIPANTS

Table 3-1: Corporate Details of Quest Diagnostics
Figure 3-1: Quest Diagnostics' Clinical Testing Sales to Third Parties, 2006-2008 and Estimated 2009 ($millions)
Table 3-2: Corporate Details of Laboratory Corporation of America
Figure 3-2: Laboratory Corporation of America' s Sales to Third Parties, 2006-2008 and Estimated 2009 ($millions)
Table 3-3: Corporate Details of Genzyme Corporation
Figure 3-3: Genzyme Corporation Testing Service Sales to Third Parties, 2006-2008 and Estimated 2009 ($millions)
Table 3-4: Corporate Details of DaVita
Figure 3-4: DaVita' s Laboratory Service Revenues, 2006-2008 and Estimated 2009 ($millions)
Table 3-5: Corporate Details of Clarient
Figure 3-5: Clarient' s Sales to Third Parties, 2006-2008 and Estimated 2009 ($millions)
Table 3-6: Corporate Details of Fresenius Medical Care AG
Table 3-7: Corporate Details of Bio-Reference Laboratories
Figure 3-6: Bio-Reference' s Sales to Third Parties, 2006-2009 ($millions)
Table 3-8: Corporate Details of Genomic Health, Inc.
Figure 3-7: Genomic Health' s Sales to Third Parties, 2006-2008 and estimated 2009 ($millions)
Table 3-9: Corporate Details of Genoptix, Inc.
Figure 3-8: Genoptix Sales to Third Parties, 2006-2008 and Estimated 2009 ($millions)

CHAPTER FOUR: ANALYSIS

Table 4-1: U.S. Clinical Laboratory Market Analysis, 2006-2013
Figure 4-1: U.S. Clinical Laboratory Market Analysis: 2006-2013
Table 4-2: U.S. Clinical Laboratory Market Analysis by Type, (Hospital-Based, Physician, Other) 2006-2013
Figure 4-2: U.S. Clinical Laboratory Market Analysis by Type, (Hopsital-Based, Phyisican, Other) 2006-2013
Figure 4-3: U.S. Clinical Laboratory Market Share by Type, (Hopsital-Based, Phyisican, Other) 2009
Figure 4-4: U.S. Clinical Laboratory Market Share by Type, (Hopsital-Based, Phyisican, Other) 2013
Table 4-3: U.S. Clinical Laboratory Market Analysis by General Test Type, (Routine vs. Specialty) 2009
Figure 4-5: U.S. Clinical Laboratory Market Analysis by General Test Type, (Routine vs. Specialty) 2009
Table 4-4: Estimated Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers 2007 and 2009
Figure 4-6: Estimated Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers 2009
Figure 4-7: Estimated Laboratory Service Revenues for Leading Clinical Laboratory Providers 2007 and 2009
Figure 4-7: Rate of Growth: Lab Corp and Quest Diagnostics 2007 and 2009